Daniele Scarinci
InvestorFounder & Managing Partner at XGEN Venture · CEO & Executive Director at Page Therapeutics
Milan, IT
About
Co-founder and Managing Partner of XGEN (2021), previously Investment Director at Genextra since 2006. Chairman of Tethis and board member of Kuste Biopharma and Page Therapeutics. Holds a degree in Economics of Financial Markets from Tor Vergata University.
Contact· self-published, not guessed
CEO & Executive Director at Page Therapeutics
Intro paths
→
In turn, Daniele can intro founders to Page Therapeutics's investors below.
Page Therapeutics's investors · 2
Co-founders at Page Therapeutics
NA

Nicola AcetoCo-founder & Chief Science Officer
CR

Christoph RochlitzCo-founder & Chief Medical Officer
Experience
- XGEN Venture SGR S.p.A.Co-Founder and Managing Partnercurrent2021 — present
- PAGE Therapeutics AGActing CEOcurrent2024 — present
- PAGE Therapeutics AGNon Executive Board Member2023
- Tethis S.p.AChairman of the Boardcurrent2022 — present
- Tethis S.p.AActing Chief Executive Officer2020 — 2022
- Tethis S.p.ANon Executive Board Member2018 — 2020
- Gesynta Pharma ABNon Executive Board Membercurrent2025 — present
- KUSTE BIOPHARMABoard Member2019 — 2024
- Genextra S.p.A.Investment Director2006 — 2022
- InnovHeart S.r.l.Board Member2015 — 2020
- FastwebBusiness Planning & Investor Relations2003 — 2006Milano, Italia
- Actinvest GroupEquity Analyst2002 — 2003Londra, Regno Unito
Colleagues at XGEN Venture
Bastiaan van der Baan
Venture Partner at XGEN Venture
Bertil Lindmark
Venture Partner at XGEN Venture
Bianca Benatti
Jr. Analyst at XGEN Venture
Carlotta Marchese
Regulatory and Corporate Affairs Specialist at XGEN Venture
Federica Draghi
Founder and Managing Partner at XGEN Venture
Gokhan Batur
Venture Partner at XGEN Venture
Graziano Piredda
Sr. Analyst at XGEN Venture
Keith Dawkins
Venture Partner at XGEN Venture
Frequently asked questions
- Who is Daniele Scarinci?
- Co-founder and Managing Partner of XGEN (2021), previously Investment Director at Genextra since 2006. Chairman of Tethis and board member of Kuste Biopharma and Page Therapeutics. Holds a degree in Economics of Financial Markets from Tor Vergata University.
- Where does Daniele Scarinci work?
- Daniele Scarinci is Founder & Managing Partner at XGEN Venture and CEO & Executive Director at Page Therapeutics.
- Where did Daniele Scarinci go to school?
- Daniele Scarinci studied at University of Rome Tor Vergata (Laurea, Economia).
Founder mafias
University of Rome Tor Vergata mafia2
Also came through, then founded or led a company.
Same school
Also attended University of Rome Tor Vergata19
Lavinia FerriAssociate at P101 VenturesStefania PonzoPartner at Pi LabsKarla MoraFounder & Managing Partner at Alante CapitalGabriele RicciChief Data & Technology Officer at Takeda VenturesAlessio FanelliPartner at Decibel PartnersBen PittariManaging Director at GP Bullhound
+ 13 more
Shared employers
Also worked at XGEN Venture SGR S.p.A.18
Federica DraghiFounder and Managing Partner at XGEN VenturePaolo FundaròFounder and Managing Partner at XGEN VentureRoberto MolinaroSenior Analyst at XGEN VentureSimona VaraniAssociate at XGEN VentureKhatereh AhmadiVenture Partner at XGEN VentureGokhan BaturVenture Partner at XGEN Venture
+ 12 more





























